Physician profile
James Gordon
NPI 1528149820
$7,449.01
in general payments reported to CMS, 2019-2025
24 companies · $3,556 in 2025
The $3,556 reported for 2025 was more than what 90% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $338 · 2021: $815 · 2022: $127 · 2023: $760 · 2024: $1,500 · 2025: $3,556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,775 · Travel and Lodging: $2,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,774.63 |
| Travel and Lodging | $2,041.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $3,007.17 | 2023-2025 | Evoke, Evoke Scs |
| Boston Scientific Corporation | $1,307.72 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, Intracept Rf Probe |
| Camber Spine Technologies LLC | $633.53 | 2021 | |
| Surgentec | $480.72 | 2023 | Tilink, Ion Facet Screw System |
| Nevro Corp. | $347.84 | 2019-2024 | Senza |
| Horizon Therapeutics Plc | $300.24 | 2019-2022 | |
| Alcon Vision LLC | $293.27 | 2024 | Rocklatan |
| Stryker Corporation | $227.54 | 2022-2025 | Mild Device Kit |
| Vertos Medical, INC. | $216.12 | 2023-2024 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $140.47 | 2021-2025 | Relistor |
| Abbott Laboratories | $95.41 | 2019-2020 | |
| Medtronic, INC. | $60.86 | 2022-2025 | Intellis Adaptivestim |
| Curonix LLC | $58.06 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbvie INC. | $44.07 | 2020 | |
| Collegium Pharmaceutical, INC. | $44.02 | 2019-2024 | Belbuca |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $39.55 | 2023 | Intracept |
| Interventional Pain Technologies INC. | $37.91 | 2021 | |
| Idorsia Pharmaceuticals US INC | $27.81 | 2022-2023 | Quviviq |
| Biotronik Nro, INC. | $22.94 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $15.60 | 2024 | |
| Medtronic USA, INC. | $13.05 | 2020 | |
| Stimwave Technologies Incorporated | $12.75 | 2020 | |
| Redhill Biopharma INC. | $11.41 | 2021 | |
| Assertio Therapeutics, INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.